IL17A and inflammatory bowel disease: As has been noted in IBD patients, a significant increase in the abundance of Enterobacteriaceae was observed in the IL-10-/- mice at 19 weeks of age and as the mice began to develop clinical signs of disease (i.e., weight loss) which was also accompanied by increased levels of IL-17 and KC in their serum.